PRIMARY HYPEROXALURIA TYPE 1
Clinical trials for PRIMARY HYPEROXALURIA TYPE 1 explained in plain language.
Never miss a new study
Get alerted when new PRIMARY HYPEROXALURIA TYPE 1 trials appear
Sign up with your email to follow new studies for PRIMARY HYPEROXALURIA TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingThis study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and m…
Matched conditions: PRIMARY HYPEROXALURIA TYPE 1
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 02, 2026 03:00 UTC
-
Researchers watch and learn: PH1 study tracks 207 patients over time
Knowledge-focused OngoingThis study follows 207 people with primary hyperoxaluria type 1 (PH1), a rare kidney disease, to see how the condition progresses over time. Researchers are also checking the long-term safety and real-world effectiveness of the drug lumasiran. Participants are not given any new t…
Matched conditions: PRIMARY HYPEROXALURIA TYPE 1
Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC